{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T09:15:49Z","timestamp":1774775749343,"version":"3.50.1"},"publisher-location":"Singapore","reference-count":70,"publisher":"Springer Singapore","isbn-type":[{"value":"9789811523847","type":"print"},{"value":"9789811523854","type":"electronic"}],"license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2020]]},"DOI":"10.1007\/978-981-15-2385-4_4","type":"book-chapter","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T14:03:02Z","timestamp":1587564182000},"page":"39-54","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Gut Microbiota and Liver Injury (II): Chronic Liver Injury"],"prefix":"10.1007","author":[{"given":"Susan S.","family":"Baker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert D.","family":"Baker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,4,23]]},"reference":[{"issue":"2","key":"4_CR1","first-page":"1","volume":"67","author":"J Xu","year":"2018","unstructured":"Xu J, Murphy SL, Kochanek KD, Bastian B, Arias E (2018) Deaths: final data for 2016. Natl Vital Stat Rep 67(2):1\u201375","journal-title":"Natl Vital Stat Rep"},{"key":"4_CR2","unstructured":"Geneva WHO (2016) Global health estimates 2016: deaths by cause, age, sex, by country and by region"},{"key":"4_CR3","doi-asserted-by":"crossref","unstructured":"Zmora N, Zilberman-Schapira G, Suez J et al (2018) Personalized gut mucosal colonization resistance to empiric probiotics is associated with unique host and microbiome features. Cell 174(6):1388\u20131405.e21","DOI":"10.1016\/j.cell.2018.08.041"},{"issue":"10","key":"4_CR4","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1038\/nrgastro.2012.157","volume":"9","author":"RB Sartor","year":"2012","unstructured":"Sartor RB (2012) Gut microbiota: diet promotes dysbiosis and colitis in susceptible hosts. Nat Rev Gastroenterol Hepatol 9(10):561\u2013562","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"7484","key":"4_CR5","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1038\/nature12820","volume":"505","author":"LA David","year":"2014","unstructured":"David LA, Maurice CF, Carmody RN et al (2014) Diet rapidly and reproducibly alters the human gut microbiome. Nature 505(7484):559\u2013563","journal-title":"Nature"},{"issue":"2","key":"4_CR6","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.cgh.2018.08.067","volume":"17","author":"TS Dong","year":"2019","unstructured":"Dong TS, Gupta A (2019) Influence of early life, diet, and the environment on the microbiome. Clin Gastroenterol Hepatol 17(2):231\u2013242","journal-title":"Clin Gastroenterol Hepatol"},{"key":"4_CR7","unstructured":"Hepatitis B. World Health Organization Fact Sheet 204 (2017)"},{"issue":"9959","key":"4_CR8","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","volume":"384","author":"C Trepo","year":"2014","unstructured":"Trepo C, Chan HL, Lok A (2014) Hepatitis B virus infection. Lancet 384(9959):2053\u20132063","journal-title":"Lancet"},{"issue":"6141","key":"4_CR9","doi-asserted-by":"publisher","first-page":"1237439","DOI":"10.1126\/science.1237439","volume":"341","author":"JJ Faith","year":"2013","unstructured":"Faith JJ, Guruge JL, Charbonneau M et al (2013) The long-term stability of the human gut microbiota. Science 341(6141):1237439","journal-title":"Science"},{"issue":"7","key":"4_CR10","doi-asserted-by":"publisher","first-page":"2175","DOI":"10.1073\/pnas.1424775112","volume":"112","author":"HH Chou","year":"2015","unstructured":"Chou HH, Chien WH, Wu LL et al (2015) Age-related immune clearance of hepatitis B virus infection requires the establishment of gut microbiota. Proc Natl Acad Sci U S A 112(7):2175\u20132180","journal-title":"Proc Natl Acad Sci U S A"},{"key":"4_CR11","doi-asserted-by":"crossref","unstructured":"Lu H, Wu Z, Xu W et al (2011) Intestinal microbiota was assessed in cirrhotic patients with hepatitis B virus infection. Intestinal microbiota of HBV cirrhotic patients. Microb Ecol 61(3):693\u2013703","DOI":"10.1007\/s00248-010-9801-8"},{"key":"4_CR12","unstructured":"Hepatitis C. World Health Organization Fact Sheet (2018)"},{"issue":"1","key":"4_CR13","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s13099-016-0124-2","volume":"8","author":"AM Aly","year":"2016","unstructured":"Aly AM, Adel A, El-Gendy AO et al (2016) Gut microbiome alterations in patients with stage 4 hepatitis C. Gut Pathog 8(1):42","journal-title":"Gut Pathog"},{"issue":"9","key":"4_CR14","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1080\/17474124.2017.1343663","volume":"11","author":"T Preveden","year":"2017","unstructured":"Preveden T, Scarpellini E, Milic N et al (2017) Gut microbiota changes and chronic hepatitis C virus infection. Expert Rev Gastroenterol Hepatol 11(9):813\u2013819","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"2","key":"4_CR15","first-page":"91","volume":"52","author":"D Munteanu","year":"2014","unstructured":"Munteanu D, Negru A, Radulescu M et al (2014) Evaluation of bacterial translocation in patients with chronic HCV infection. Rom J Intern Med 52(2):91\u201396","journal-title":"Rom J Intern Med"},{"issue":"6","key":"4_CR16","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1111\/apt.13732","volume":"44","author":"JS Bajaj","year":"2016","unstructured":"Bajaj JS, Sterling RK, Betrapally NS et al (2016) HCV eradication does not impact gut dysbiosis or systemic inflammation in cirrhotic patients. Aliment Pharmacol Ther 44(6):638\u2013643","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"4_CR17","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1586\/egh.13.21","volume":"7","author":"AJ Czaja","year":"2013","unstructured":"Czaja AJ (2013) Autoimmune hepatitis in diverse ethnic populations and geographical regions. Expert Rev Gastroenterol Hepatol 7(4):365\u2013385","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"3","key":"4_CR18","doi-asserted-by":"publisher","first-page":"1481","DOI":"10.4049\/jimmunol.170.3.1481","volume":"170","author":"N Kerkar","year":"2003","unstructured":"Kerkar N, Choudhuri K, Ma Y et al (2003) Cytochrome P4502D6(193\u2013212): a new immunodominant epitope and target of virus\/self cross-reactivity in liver kidney microsomal autoantibody type 1-positive liver disease. J Immunol 170(3):1481\u20131489","journal-title":"J Immunol"},{"issue":"5","key":"4_CR19","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1002\/hep.27998","volume":"62","author":"M Yuksel","year":"2015","unstructured":"Yuksel M, Wang Y, Tai N et al (2015) A novel \u201chumanized mouse\u201d model for autoimmune hepatitis and the association of gut microbiota with liver inflammation. Hepatology 62(5):1536\u20131550","journal-title":"Hepatology"},{"issue":"5","key":"4_CR20","first-page":"5153","volume":"8","author":"R Lin","year":"2015","unstructured":"Lin R, Zhou L, Zhang J et al (2015) Abnormal intestinal permeability and microbiota in patients with autoimmune hepatitis. Int J Clin Exp Pathol 8(5):5153\u20135160","journal-title":"Int J Clin Exp Pathol"},{"issue":"42","key":"4_CR21","doi-asserted-by":"publisher","first-page":"9257","DOI":"10.3748\/wjg.v22.i42.9257","volume":"22","author":"AJ Czaja","year":"2016","unstructured":"Czaja AJ (2016) Factoring the intestinal microbiome into the pathogenesis of autoimmune hepatitis. World J Gastroenterol 22(42):9257\u20139278","journal-title":"World J Gastroenterol"},{"issue":"10","key":"4_CR22","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1111\/apt.14324","volume":"46","author":"AJ Czaja","year":"2017","unstructured":"Czaja AJ (2017) Review article: next-generation transformative advances in the pathogenesis and management of autoimmune hepatitis. Aliment Pharmacol Ther 46(10):920\u2013937","journal-title":"Aliment Pharmacol Ther"},{"key":"4_CR23","doi-asserted-by":"crossref","unstructured":"Tsuneyama K, Baba H, Morimoto Y et al (2017) Primary biliary cholangitis: its pathological characteristics and immunopathological mechanisms. J Med Invest 64(1.2):7\u201313","DOI":"10.2152\/jmi.64.7"},{"issue":"3","key":"4_CR24","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1136\/flgastro-2018-101109","volume":"10","author":"JC Goet","year":"2019","unstructured":"Goet JC, Hirschfield GM (2019) Guideline review: British Society of Gastroenterology\/UK-PBC Primary Biliary Cholangitis treatment and management guidelines. Frontline Gastroenterol 10(3):316\u2013319","journal-title":"Frontline Gastroenterol"},{"issue":"9","key":"4_CR25","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1016\/j.autrev.2017.07.002","volume":"16","author":"Y Li","year":"2017","unstructured":"Li Y, Tang R, Leung PSC et al (2017) Bile acids and intestinal microbiota in autoimmune cholestatic liver diseases. Autoimmun Rev 16(9):885\u2013896","journal-title":"Autoimmun Rev"},{"issue":"7","key":"4_CR26","doi-asserted-by":"publisher","first-page":"2271","DOI":"10.1111\/1462-2920.13401","volume":"18","author":"L-X Lv","year":"2016","unstructured":"Lv L-X, Fang D-Q, Shi D et al (2016) Alterations and correlations of the gut microbiome, metabolism and immunity in patients with primary biliary cirrhosis. Environ Microbiol 18(7):2271\u20132286","journal-title":"Environ Microbiol"},{"issue":"3","key":"4_CR27","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1136\/gutjnl-2016-313332","volume":"67","author":"R Tang","year":"2018","unstructured":"Tang R, Wei Y, Li Y et al (2018) Gut microbial profile is altered in primary biliary cholangitis and partially restored after UDCA therapy. Gut 67(3):534\u2013541","journal-title":"Gut"},{"issue":"3","key":"4_CR28","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1097\/MOG.0000000000000352","volume":"33","author":"AC Cheung","year":"2017","unstructured":"Cheung AC, Lazaridis KN, LaRusso NF et al (2017) Emerging pharmacologic therapies for primary sclerosing cholangitis. Curr Opin Gastroenterol 33(3):149\u2013157","journal-title":"Curr Opin Gastroenterol"},{"key":"4_CR29","doi-asserted-by":"crossref","unstructured":"Tabibian JH, O\u2019Hara SP, Lindor KD (2014) Primary sclerosing cholangitis and the microbiota: current knowledge and perspectives on etiopathogenesis and emerging therapies. Scand J Gastroenterol 49(8):901\u2013908","DOI":"10.3109\/00365521.2014.913189"},{"issue":"3","key":"4_CR30","doi-asserted-by":"publisher","first-page":"426","DOI":"10.1016\/S0168-8278(98)80316-4","volume":"28","author":"R Olsson","year":"1998","unstructured":"Olsson R, Bjornsson E, Backman L et al (1998) Bile duct bacterial isolates in primary sclerosing cholangitis: a study of explanted livers. J Hepatol 28(3):426\u2013432","journal-title":"J Hepatol"},{"issue":"9","key":"4_CR31","doi-asserted-by":"publisher","first-page":"2265","DOI":"10.1007\/s10620-007-9803-7","volume":"52","author":"AM Krasinskas","year":"2007","unstructured":"Krasinskas AM, Yao Y, Randhawa P et al (2007) Helicobacter pylori may play a contributory role in the pathogenesis of primary sclerosing cholangitis. Dig Dis Sci 52(9):2265\u20132270","journal-title":"Dig Dis Sci"},{"issue":"7112","key":"4_CR32","doi-asserted-by":"publisher","first-page":"1110","DOI":"10.1016\/S0140-6736(59)90098-4","volume":"2","author":"JG Rankin","year":"1959","unstructured":"Rankin JG, Boden RW, Goulston SJ et al (1959) The liver in ulcerative colitis; treatment of pericholangitis with tetracycline. Lancet 2(7112):1110\u20131112","journal-title":"Lancet"},{"issue":"6","key":"4_CR33","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1111\/apt.12232","volume":"37","author":"JH Tabibian","year":"2013","unstructured":"Tabibian JH, Weeding E, Jorgensen RA et al (2013) Randomised clinical trial: vancomycin or metronidazole in patients with primary sclerosing cholangitis\u2014a pilot study. Aliment Pharmacol Ther 37(6):604\u2013612","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"4_CR34","doi-asserted-by":"publisher","first-page":"e56","DOI":"10.1097\/MJT.0000000000000102","volume":"24","author":"JH Tabibian","year":"2017","unstructured":"Tabibian JH, Gossard A, El-Youssef M et al (2017) Prospective clinical trial of rifaximin therapy for patients with primary sclerosing cholangitis. Am J Ther 24(1):e56\u2013e63","journal-title":"Am J Ther"},{"issue":"1","key":"4_CR35","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1097\/MPG.0b013e31816fee95","volume":"47","author":"YK Davies","year":"2008","unstructured":"Davies YK, Cox KM, Abdullah BA et al (2008) Long-term treatment of primary sclerosing cholangitis in children with oral vancomycin: an immunomodulating antibiotic. J Pediatr Gastroenterol Nutr 47(1):61\u201367","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"10","key":"4_CR36","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1007\/s00018-016-2161-x","volume":"73","author":"W Liu","year":"2016","unstructured":"Liu W, Baker RD, Bhatia T et al (2016) Pathogenesis of nonalcoholic steatohepatitis. Cell Mol Life Sci 73(10):1969\u20131987","journal-title":"Cell Mol Life Sci"},{"issue":"2","key":"4_CR37","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1002\/hep.26093","volume":"57","author":"L Zhu","year":"2013","unstructured":"Zhu L, Baker SS, Gill C et al (2013) Characterization of gut microbiomes in nonalcoholic steatohepatitis (NASH) patients: a connection between endogenous alcohol and NASH. Hepatology 57(2):601\u2013609","journal-title":"Hepatology"},{"issue":"7","key":"4_CR38","doi-asserted-by":"publisher","first-page":"1932","DOI":"10.1007\/s10620-012-2112-9","volume":"57","author":"V Volynets","year":"2012","unstructured":"Volynets V, Kuper MA, Strahl S et al (2012) Nutrition, intestinal permeability, and blood ethanol levels are altered in patients with nonalcoholic fatty liver disease (NAFLD). Dig Dis Sci 57(7):1932\u20131941","journal-title":"Dig Dis Sci"},{"key":"4_CR39","unstructured":"Baker RD, Greer FR  (2010) Diagnosis and prevention of iron deficiency and iron-deficiency anemia in infants and young children (0\u20133\u00a0years of age). Pediatrics 126(5):1040\u20131050"},{"issue":"6052","key":"4_CR40","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1126\/science.1208344","volume":"334","author":"GD Wu","year":"2011","unstructured":"Wu GD, Chen J, Hoffmann C et al (2011) Linking long-term dietary patterns with gut microbial enterotypes. Science 334(6052):105\u2013108","journal-title":"Science"},{"key":"4_CR41","doi-asserted-by":"crossref","unstructured":"Zhu L, Baker RD, Baker SS (2015) Gut microbiome and nonalcoholic fatty liver diseases. Pediatr Res 77(1\u20132):245\u2013251","DOI":"10.1038\/pr.2014.157"},{"issue":"2","key":"4_CR42","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/0006-3002(56)90148-2","volume":"22","author":"EA Dawes","year":"1956","unstructured":"Dawes EA, Foster SM (1956) The formation of ethanol in Escherichia coli. Biochim Biophys Acta 22(2):253\u2013265","journal-title":"Biochim Biophys Acta"},{"issue":"8","key":"4_CR43","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1111\/j.1530-0277.1998.tb03972.x","volume":"22","author":"RK Rao","year":"1998","unstructured":"Rao RK (1998) Acetaldehyde-induced increased in paracellular permeability in Caco-2 cell monolayer. Alcohol Clin Exp Res 22(8):1724\u20131730","journal-title":"Alcohol Clin Exp Res"},{"key":"4_CR44","unstructured":"Wostmann BS, Larkin C, Moriarty A et al (1983) Dietary intake, energy metabolism, and excretory losses of adult male germfree Wistar rats. Lab Anim Sci 33:46\u201350"},{"issue":"1","key":"4_CR45","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1038\/oby.2009.167","volume":"18","author":"A Schwiertz","year":"2010","unstructured":"Schwiertz A, Taras D, Schafer K et al (2010) Microbiota and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring) 18(1):190\u2013195","journal-title":"Obesity (Silver Spring)"},{"issue":"9","key":"4_CR46","doi-asserted-by":"publisher","first-page":"2325","DOI":"10.1194\/jlr.R036012","volume":"54","author":"G Besten den","year":"2013","unstructured":"den Besten G, van Eunen K, Groen AK et al (2013) The role of short-chain fatty acids in the interplay between diet, gut microbiota, and host energy metabolism. J Lipid Res 54(9):2325\u20132340","journal-title":"J Lipid Res"},{"issue":"7","key":"4_CR47","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.2337\/db14-1213","volume":"64","author":"G Besten den","year":"2015","unstructured":"den Besten G, Bleeker A, Gerding A et al (2015) Short-chain fatty acids protect against high-fat diet-induced obesity via a PPARgamma-dependent switch from lipogenesis to fat oxidation. Diabetes 64(7):2398\u20132408","journal-title":"Diabetes"},{"key":"4_CR48","doi-asserted-by":"crossref","unstructured":"Sasabe J, Suzuki M (2018) Emerging role of D-amino acid metabolism in the innate defense. Front Microbiol 9:933","DOI":"10.3389\/fmicb.2018.00933"},{"key":"4_CR49","unstructured":"Foundation AL (2019) Liver disease statistics. \nhttps:\/\/liverfoundation.org\/liver-disease-statistics\/#alcohol-related-liver-disease-and-cirrhosis\n\n. Accessed 30 June 2019"},{"issue":"3","key":"4_CR50","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1177\/0115426506021003245","volume":"21","author":"SR DiCecco","year":"2006","unstructured":"DiCecco SR, Francisco-Ziller N (2006) Nutrition in alcoholic liver disease. Nutr Clin Pract 21(3):245\u2013254","journal-title":"Nutr Clin Pract"},{"issue":"7","key":"4_CR51","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/nure.12027","volume":"71","author":"EE Elamin","year":"2013","unstructured":"Elamin EE, Masclee AA, Dekker J et al (2013) Ethanol metabolism and its effects on the intestinal epithelial barrier. Nutr Rev 71(7):483\u2013499","journal-title":"Nutr Rev"},{"issue":"12","key":"4_CR52","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1056\/NEJMe1000850","volume":"362","author":"SM Riordan","year":"2010","unstructured":"Riordan SM, Williams R (2010) Gut flora and hepatic encephalopathy in patients with cirrhosis. N Engl J Med 362(12):1140\u20131142","journal-title":"N Engl J Med"},{"issue":"9","key":"4_CR53","doi-asserted-by":"publisher","first-page":"G966","DOI":"10.1152\/ajpgi.00380.2011","volume":"302","author":"EA Mutlu","year":"2012","unstructured":"Mutlu EA, Gillevet PM, Rangwala H et al (2012) Colonic microbiome is altered in alcoholism. Am J Physiol Gastrointest Liver Physiol 302(9):G966\u2013G978","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"4_CR54","doi-asserted-by":"crossref","unstructured":"Tuomisto S, Pessi T, Collin P et al (2014) Changes in gut bacterial populations and their translocation into liver and ascites in alcoholic liver cirrhotics. BMC Gastroenterol 14:40","DOI":"10.1186\/1471-230X-14-40"},{"issue":"2","key":"4_CR55","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1002\/hep.24423","volume":"54","author":"Y Chen","year":"2011","unstructured":"Chen Y, Yang F, Lu H et al (2011) Characterization of fecal microbial communities in patients with liver cirrhosis. Hepatology 54(2):562\u2013572","journal-title":"Hepatology"},{"issue":"1","key":"4_CR56","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.jhep.2005.10.013","volume":"44","author":"G D\u2019Amico","year":"2006","unstructured":"D\u2019Amico G, Garcia-Tsao G, Pagliaro L (2006) Natural history and prognostic indicators of survival in cirrhosis: a systematic review of 118 studies. J Hepatol 44(1):217\u2013231","journal-title":"J Hepatol"},{"key":"4_CR57","doi-asserted-by":"crossref","unstructured":"Bajaj JS, Vargas HE, Reddy KR et al (2019) Association between intestinal microbiota collected at hospital admission and outcomes of patients with cirrhosis. Clin Gastroenterol Hepatol 17(4):756\u2013765.e3","DOI":"10.1016\/j.cgh.2018.07.022"},{"issue":"6","key":"4_CR58","doi-asserted-by":"publisher","first-page":"G675","DOI":"10.1152\/ajpgi.00152.2012","volume":"303","author":"JS Bajaj","year":"2012","unstructured":"Bajaj JS, Hylemon PB, Ridlon JM et al (2012) Colonic mucosal microbiome differs from stool microbiome in cirrhosis and hepatic encephalopathy and is linked to cognition and inflammation. Am J Physiol Gastrointest Liver Physiol 303(6):G675\u2013G685","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"issue":"6","key":"4_CR59","doi-asserted-by":"publisher","first-page":"1336","DOI":"10.1016\/j.jhep.2012.06.026","volume":"57","author":"R Jalan","year":"2012","unstructured":"Jalan R, Gines P, Olson JC et al (2012) Acute-on chronic liver failure. J Hepatol 57(6):1336\u20131348","journal-title":"J Hepatol"},{"key":"4_CR60","doi-asserted-by":"crossref","unstructured":"Laleman W, Verbeke L, Meersseman P et al (2011) Acute-on-chronic liver failure: current concepts on definition, pathogenesis, clinical manifestations and potential therapeutic interventions. Expert Rev Gastroenterol Hepatol 5(4):523\u2013537; quiz 37","DOI":"10.1586\/egh.11.47"},{"issue":"6086","key":"4_CR61","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1126\/science.1223490","volume":"336","author":"LV Hooper","year":"2012","unstructured":"Hooper LV, Littman DR, Macpherson AJ (2012) Interactions between the microbiota and the immune system. Science 336(6086):1268\u20131273","journal-title":"Science"},{"issue":"9","key":"4_CR62","doi-asserted-by":"publisher","first-page":"1429","DOI":"10.1111\/jgh.12932","volume":"30","author":"YF Chen","year":"2015","unstructured":"Chen YF, Guo J, Qian GR et al (2015) Gut dysbiosis in acute-on-chronic liver failure and its predictive value for mortality. J Gastroenterol Hepatol 30(9):1429\u20131437","journal-title":"J Gastroenterol Hepatol"},{"issue":"6","key":"4_CR63","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1017\/S148180350001424X","volume":"8","author":"S Arora","year":"2006","unstructured":"Arora S, Martin CL, Herbert M (2006) Myth: interpretation of a single ammonia level in patients with chronic liver disease can confirm or rule out hepatic encephalopathy. CJEM 8(6):433\u2013435","journal-title":"CJEM"},{"issue":"3","key":"4_CR64","doi-asserted-by":"publisher","first-page":"397","DOI":"10.4161\/gmic.28684","volume":"5","author":"JS Bajaj","year":"2014","unstructured":"Bajaj JS (2014) The role of microbiota in hepatic encephalopathy. Gut Microbes 5(3):397\u2013403","journal-title":"Gut Microbes"},{"issue":"1","key":"4_CR65","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/hep.28121","volume":"63","author":"D Kao","year":"2016","unstructured":"Kao D, Roach B, Park H et al (2016) Fecal microbiota transplantation in the management of hepatic encephalopathy. Hepatology 63(1):339\u2013340","journal-title":"Hepatology"},{"issue":"8575\u20138576","key":"4_CR66","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S0140-6736(88)91033-1","volume":"1","author":"PA Leeuwen van","year":"1988","unstructured":"van Leeuwen PA, van Berlo CL, Soeters PB (1988) New mode of action for lactulose. Lancet 1(8575\u20138576):55\u201356","journal-title":"Lancet"},{"issue":"2","key":"4_CR67","first-page":"2954","volume":"8","author":"Y Zhang","year":"2015","unstructured":"Zhang Y, Feng Y, Cao B et al (2015) Effects of SIBO and rifaximin therapy on MHE caused by hepatic cirrhosis. Int J Clin Exp Med 8(2):2954\u20132957","journal-title":"Int J Clin Exp Med"},{"issue":"9","key":"4_CR68","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1038\/nrgastro.2017.72","volume":"14","author":"LX Yu","year":"2017","unstructured":"Yu LX, Schwabe RF (2017) The gut microbiome and liver cancer: mechanisms and clinical translation. Nat Rev Gastroenterol Hepatol 14(9):527\u2013539","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"4_CR69","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1002\/hep.30036","volume":"69","author":"FR Ponziani","year":"2019","unstructured":"Ponziani FR, Bhoori S, Castelli C et al (2019) Hepatocellular carcinoma is associated with gut microbiota profile and inflammation in nonalcoholic fatty liver disease. Hepatology 69(1):107\u2013120","journal-title":"Hepatology"},{"issue":"6","key":"4_CR70","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1136\/gutjnl-2017-315084","volume":"68","author":"Z Ren","year":"2019","unstructured":"Ren Z, Li A, Jiang J et al (2019) Gut microbiome analysis as a tool towards targeted non-invasive biomarkers for early hepatocellular carcinoma. Gut 68(6):1014\u20131023","journal-title":"Gut"}],"container-title":["Advances in Experimental Medicine and Biology","Gut Microbiota and Pathogenesis of Organ Injury"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/978-981-15-2385-4_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T14:06:23Z","timestamp":1587564383000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/978-981-15-2385-4_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020]]},"ISBN":["9789811523847","9789811523854"],"references-count":70,"URL":"https:\/\/doi.org\/10.1007\/978-981-15-2385-4_4","relation":{},"ISSN":["0065-2598","2214-8019"],"issn-type":[{"value":"0065-2598","type":"print"},{"value":"2214-8019","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020]]},"assertion":[{"value":"23 April 2020","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}